Post-COVID-19 Pulmonary Inflammatory Pseudotumors Treated With Steroid Taper

Area of Science:

• Pulmonology
• Pathology
• Infectious Diseases

Background:

• COVID-19 can lead to diverse and prolonged pulmonary complications.
• Pulmonary inflammatory pseudotumors (PIPs) are rare benign lung lesions.
• PIPs mimic malignant neoplasms clinically and radiologically.

Observation:

• A 58-year-old patient developed PIPs after recovering from COVID-19.
• Histology revealed myofibroblastic spindle cells and inflammatory infiltrates.
• The case highlights a novel post-viral sequela.

Findings:

• This is the first reported case of COVID-19-associated PIPs.
• Diagnosis presented challenges due to resemblance to malignancy.
• Successful management involved corticosteroid therapy.

Implications:

• Corticosteroids are effective in managing post-COVID-19 PIPs.
• This finding expands the spectrum of post-COVID-19 pulmonary complications.
• Further research is needed on the COVID-19 and PIPs interplay.